A novel aminoglycoside antibiotic, boholmycin, was produced by Streptomyces hygroscopicus H617-25 isolated from a soil sample collected in Bohol Island, the Philippines. It has a pseudotetrasaccharide structure composedof a heptose, two aminosugars and dicarbamoyl-^c^//(?-inositol.
Intrinsic antibacterial activity of boholmycin is weak but it exhibits broad spectrum activity against Gram-positive and Gram-negative bacteria including aminoglycoside-resistant strains. Boholmycin is non-toxic in mice at 1,000 mg/kg intravenously.
In the course of our screening program for new antibiotics, a Streptomyces strain, No. H617-25, was found to produce a new aminoglycoside antibiotic named boholmycin after the source of its producing organism. The antibiotic showed broad spectrum activity against Gram-positive and Gramnegative bacteria including aminoglycoside-resistant strains, and was effective in vivo against bacterial infections. The antibiotic was non-toxic in mice at 1,000 mg/kg, iv. Boholmycin is a new type of aminoglycoside antibiotic structurally unrelated to knownantibiotics1}. This paper describes the taxonomy of the producing organism, production, isolation, physico-chemical and biological properties of boholmycin. The determination of the structure will be the subject of a second publication.
Producing Organism
Strain H617-25 was isolated from a soil sample collected from Bohol Island of the Philippines. It forms aerial and substrate mycelia with abundant sporulation. The color of the aerial mycelium is white or pale orange yellow, later turns to brownish shade of gray. This strain forms coiled sporechains on monopodially branched aerial sporophores. Tightly coiled spore-chain containing 10 to 50 arthrospdres are often formed. The spores are short-cylindrical, 0.6~0.8 x0.8~1.2 jam in size, and have rugose or smooth surfaces. A hygroscopic change on the aerial mycelium occurs often in some agar media such as ISP Nos. 4 and 5.
Strain H617-25 grows well and forms aerial mycelium in both nutritionally rich organic media and chemically defined agar media except for ISP Nos. grows on agar mediumcontaining NaCl at 6%but not at 8%. Whorl sporophore, motile spore and sporangium are not observed in any of the media examined. These cultural and physiological characteristics as well as the pattern of carbohydrate utilization of strain H617-25 indicate that it belongs to the genus Streptomyces. According to the descriptions in Bergey's Manual2), strain H617-25 resembles the species group, spirales, gray series, non^chromogenie, and smooth spore surface, which includes 65 species and 7 subspecies. Hygroscopic change of the aerial mycelium (blackening and moistening) is an additional important property of strain H617-25. By comparison of these results with the descriptions in the Bergey's Manual2) and those of Dietz3), it was concluded that strain H61 7-25 belongs to the species, Streptomyces hygroscopicus.
Antibiotic Production A well-grown agar slant of S. hygroscopicus strain No. H617-25, was used to inoculate a vegetative medium consisting of glycerol 3 %, Bacto-liver 1 %, corn steep liquor 0.5%, (NH4)2SO4 0.1 %\NaCl 0.3 %and CaCO30.6%, adjusted to pH 7.0 before sterilization.
The medium was incubated at 28°C for 4 days on a rotary shaker (250 rpm). Five ml of the growth was transferred to a 500-ml Erlenmeyer flask containing 100 ml of the same medium. The fermentation was run at 28°C with shaking on rotary shaker at 250 rpm. The antibiotic activity in the fermentation broth was determined by the paper-disc agar diffusion method using Bacillus subtilis PCI 219 as the test organism. A maximal antibiotic potency of approximately 500 //g/ml was obtained after 4 to 5 days fermentation. The fermentation was also carried out in stir-jar fermentors. A 500-ml portion of the seed culture from flask fermentation was inoculated to 12 liters of mediumin a 20-liter jar fermentor which was run at 28°C with agitation at 250 rpm and aeration at 10 liters per minute. Antibiotic production reached a maximumof 300^g/ml after about 90 hours fermentation.
Isolation and Purification
The harvested broth (47 liters, 300^g/ml) was centrifuged using a Sharpless centrifuge (Kokusan No. 4A). The clarified fermentation liquor was adjusted to pH 7.0 and stirred with Amberlite IRC-50 (6 liters, 60% NH4+) to adsorb the antibiotic activity. The resin was washed with water and the antibiotic was eluted batchwise with 0.5 n NH4OH(10 liters x2). The eluates were pooled and concentrated in vacuo to a small volume (300 ml). The concentrate was diluted with an equal volume of methanol and added into acetone (9 liters) to precipitate crude boholmycin (30.1 g). The crude solid was dissolved in 100 ml of water and applied on a column of CM-Sephadex C-25 (2.4 liters, NH4+). The column was eluted with a linear gradient of water and 1.0 m NH4C1solution (4 liters each). The eluates were collected in 30-ml fractions with an activity peak observed at fraction Nos. 221~240. The combined active fractions were loaded on a column of Sephadex LH-20 (8.4 liters) which was preequilibrated with 50%aqueous methanol. The column was developed with the same solvent and the elution of the antibiotic was monitored by TLC(solvent system, CHC13-MeOHcone NH4OH-H2O, 1 :4 :2 : 1) and bioassay (B. subtilis PCI 219). The fractions containing boholmycin were pooled, concentrated in vacuo and lyophilized to afford white powder of boholmycin hydrochloride (1 3 g).
Physico-chemical
Properties Boholmycin is a water-soluble, weakly basic antibiotic. It is freely soluble in water, slightly soluble in methanol and ethanol but practically insoluble in other organic solvents. Boholmycin gave a positive reaction in ninhydrin and anthrone tests, but was negative to Tollen's and Sakaguchi reagents. The antibiotic was reasonably stable in neutral and acidic solution but unstable in alkaline solution. The physico-chemical properties of boholmycin are summarized in Table 1 . It has no UVabsorption maximumabove 210 nm. The molecular formula was assigned as C27H48N4O21 based on the elemental analysis of its hydrochloride and field desorption mass spectrometry (FD-MS) (M+ H m/z 765). The 13C NMRspectrum indicated 25 signals with two of them having a double intensity. The IR spectrum (Fig. 2) shows strong absorption bands at 1720 and 1610 cm"1 which are attributable to O-carbamoyl group. The XHNMRspectrum (Fig. 3) streptomycin, glebomycin4) and myomycinB5), which are in some respects chemically related to boholmycin (Table 2) .
Biological Properties In Vitro Antibacterial Activity The MICsof boholmycin were determined by a serial agar dilution method in comparison with sorbistin Ai6), streptomycin and kanamycin. Nutrient agar (Difco) was used for all bacteria except for strains of Mycobacterium which were tested in No. 1001 agar. As shown in Table 3 , the antibacterial activity of boholmycin was comparable to that of sorbistin Ax but generally weaker than that of streptomycin or kanamycin. However, boholmycin was as active against kanamycin-and streptomycin-resistant organisms as against the sensitive ones. Like the streptomycin-group of antibiotics, boholmycin induced the growth of a streptomycin-dependent strain of Escherichia coli D64 (Table 4) . MyomycinB was also found to stimulate the growth of this organism.
In Vivo Activity The in vivo efficacy of boholmycin was tested in mice against experimental infections produced by Staphylococcus aureus, E. coli and Klebsiella pneumoniae. Mice were challenged with a multiple of the lethal dose of the pathogens in a 5 %-suspension of gastric mucin (American Laboratory, Omaha, Neb.). Boholmycin was administered intramuscularly just before the bacterial challenge. The mice were observed for 5 days to determine the median protective dose (PD50). Sorbistin Al9 streptomycin and kanamycin were comparatively tested as reference antibiotics. Boholmycinand sorbistin Ax showed similar in vivo activity but were muchless active than streptomycin and kanamycin (Table  5) . Boholmycin did not show any toxic signs in mice up to a dose of 1,000 mg/kg by intravenous administrati on.
Discussion
Boholmycin is a novel aminoglycoside antibiotic elaborated by a strain of S. hygroscopicus H617-25. Although its intrinsic activity is not potent, boholmycin shows broad antibacterial activity against Gram-positive, Gram-negative and acid-fast bacteria in vitro and in vivo. Structural studies revealed that boholmycin is a new type of pseudotetrasaccharide antibiotic consisting of a heptose, two aminosugars and a dicarbamoyl-5>cy//0-inositol (Fig. 1 ).
